Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Consolidation with Nivolumab and Brentuximab Vedotin after Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-136384

Published: 2020

Journal Articles

Clinical Outcomes of Chronic Lymphocytic Leukemia (CLL) Patients with Richter's Transformation (RT) to Aggressive Non-Hodgkin Lymphoma (aNHL): a Single-Institution Experience

Mazyar Shadman, MDMPH, Sirin Khajavian, MD, Andrew J. Cowan, MD, Andrei R. Shustov, MD, Brian G Till, MD, Ryan D. Cassaday, MD, Mohamed L Sorror, MD MSc, Leona Holmberg, MD PhD, E Houston Warren, MDPhD, Lori Soma, MD, Edward N. Libby, III, MD, David G. Maloney, MD PhD, Ajay K. Gopal, MD, Oliver W. Press, MD PhD, Stephen D. Smith, MD

Blood (2017) 130 (Supplement 1): 4308.

https://doi.org/10.1182/blood.V130.Suppl_1.4308.4308

Published: 2017

Journal Articles

A Phase II Trial Evaluating the Efficacy of Radioiodinated Tositumomab (Anti-CD20) Antibody, Etoposide and Cyclophosphamide Followed By Autologous Transplantation, for High-Risk Relapsed or Refractory Non-Hodgkin's Lymphoma

Victor A. Chow, MD, Joseph Rajendren, MD, Andrew Shields, MD, Darrell R. Fisher, PhD, Frederick R. Appelbaum, MD, Ryan D. Cassaday, MD, Andrew J. Cowan, MD, Paul J. Martin, MD, Leona Holmberg, MD PhD, Ted Gooley, PhD, Philip A. Stevenson, MS, John M. Pagel, MD PhD, Damian J. Green, MD, Oliver W. Press, MD PhD, Ajay K. Gopal, MD

Blood (2017) 130 (Supplement 1): 2018.

https://doi.org/10.1182/blood.V130.Suppl_1.2018.2018

Published: 2017

Journal Articles

Phase II Trial of Bortezomib Plus Rituximab As Maintenance Therapy Post ASCT for Patients with Mantle Cell Lymphoma

Robert W. Chen, MD, Joycelynne M. Palmer, PhD, Leslie Popplewell**, MD, Jessica Alluin, Pritsana Chomchan, Auayporn P. Nademanee, MDBS, Tanya Siddiqi, MD, Nicole Tsai, Fay Zuo, Rosie Abary, Ji-lian Cai, Steven T. Rosen, MD, Stephen J. Forman, MD FACP, Larry W Kwak, MDPhD, Leona Holmberg, MD PhD

Blood (2017) 130 (Supplement 1): 4515.

https://doi.org/10.1182/blood.V130.Suppl_1.4515.4515

Published: 2017

Journal Articles

Bone Marrow Involvement Detected By Multi-Parameter Flow Cytometry Predicts Poor Outcome after Autologous Stem Cell Transplantation for Peripheral T-Cell Lymphoma

Jordan Gauthier, MDMSc, Leona Holmberg, MD PhD, David Wu, MD PhD, William I. Bensinger, MD, Ajay K. Gopal, MD, Oliver W. Press, MD PhD, David G Maloney, MD PhD, Damian J. Green, MD, Brian G. Till, MD, Denys Byelykh, MD, Andrei R. Shustov, MD

Blood (2015) 126 (23): 1972.

https://doi.org/10.1182/blood.V126.23.1972.1972

Published: 2015

Journal Articles

Failure of Intensified Induction Therapy and Inability to Undergo Stem Cell Transplantation Predict Dismal Outcomes in Relapsed/Refractory MYC + B-Cell Lymphoma

Ryan D. Cassaday, MD, Philip A. Stevenson, MS, Bronwyn H. Bryant, MD, Cecilia Yeung, MD, Brian G. Till, MD, Stephen D. Smith, MD, Edward N. Libby, MD, Andrei R. Shustov, MD, John M. Pagel, MD PhD, Damian J. Green, MD, Mary Philip, MD PhD, Johnnie J. Orozco, MD PhD, Min Fang, MD PhD, Leona Holmberg, MD PhD, William I. Bensinger, MD, David G Maloney, MDPhD, Ajay K. Gopal, MD, Oliver W. Press, MD PhD

Blood (2014) 124 (21): 1731.

https://doi.org/10.1182/blood.V124.21.1731.1731

Published: 2014

Journal Articles

Long Term Follow-up of High-Dose CD20-Targeted Radioimmunotherapy-Based Autologous Transplantation for Patients with Mantle Cell Lymphoma

Ryan D. Cassaday, MD, Philip A. Stevenson, MS, Theodore A. Gooley, PhD, Thomas Chauncey, MD PhD, John Pagel, MD PhD, Brian G. Till, MD, Mary Philip, MD PhD, Johnnie J. Orozco, MD PhD, William I. Bensinger, MD, Leona Holmberg, MD PhD, Andrei R. Shustov, MD, Damian J. Green, MD, Stephen D. Smith, MD, Edward N. Libby, MD, David G Maloney, MDPhD, Lorinda A. Soma, MD, Oliver W. Press, MD PhD, Ajay K. Gopal, MD

Blood (2014) 124 (21): 3967.

https://doi.org/10.1182/blood.V124.21.3967.3967

Published: 2014

Journal Articles

Bendamustine (Treanda®)-Based Regimens Are Effective In Mobilizing Peripheral Blood Hematopoietic Stem Cells For Autologous Transplantation

Damian J. Green, MD, William I. Bensinger, MD, Leona Holmberg, MD, PhD, Theodore A. Gooley, PhD, Brian G. Till, MD, Lihua Elizabeth Budde, MD, PhD, John M. Pagel, MD, PhD, Shani L. Frayo, BS, Jennifer E. Roden, Lacey M. Hedin, Malcolm Mack, Oliver W. Press, MD, PhD, Ajay K. Gopal, MD

Blood (2013) 122 (21): 2033.

https://doi.org/10.1182/blood.V122.21.2033.2033

Published: 2013

Journal Articles

Cost and Utilization Of Stored Autologous PBSC To Support Tandem ASCT In MM Patients In The Era Of Novel Agent Therapy

Colin Phipps, MD, Michael L. Linenberger, MD, Damian J. Green, MD, M. Corinna Palanca-Wessels, MD, PhD, Pamela S. Becker, MD, PhD, Laura S. Connelly-Smith, MBBCh, DM, Nicholas Burwick, MD, Zandra K. Klippel, MD, William I. Bensinger, MD, Leona Holmberg, MD, PhD, Edward N. Libby, III, MD

Blood (2013) 122 (21): 4507.

https://doi.org/10.1182/blood.V122.21.4507.4507

Published: 2013

Journal Articles

Impact Of Pre-Transplant Rituximab Sensitivity In Relapsed Follicular Lymphoma On Outcome After Autologous Transplant

Colin Phipps, MD, Ajay K. Gopal, MD, Barry E. Storer, PhD, Ryan D. Cassaday, MD, Oliver W. Press, MD, PhD, Brian G. Till, MD, John M. Pagel, MD, PhD, Mary Phillip, Maria Corinna Palanca-Wessels, M.D., Ph.D., William I. Bensinger, MD, Leona Holmberg, MD, PhD, Andrei R. Shustov, MD, Damian J. Green, MD, Thomas Chauncey, MD, PhD, David G. Maloney, MD, PhD, Edward N. Libby, III, MD

Blood (2013) 122 (21): 3365.

https://doi.org/10.1182/blood.V122.21.3365.3365

Published: 2013

Journal Articles

Brentuximab Vedotin Administered To Platinum-Refractory Transplant Naïve Hodgkin Lymphoma Patients Can Increase The Proportion Achieving FDG-PET Negative Status

Maika Onishi, MD, Leona Holmberg, MD, PhD, Andrei R. Shustov, MD, Karen Schiavo, ARNP, Mary Philip, MD, PhD, Edward N. Libby, III, MD, Ryan D. Cassaday, MD, John M. Pagel, MD, PhD, David G. Maloney, MD, PhD, Damian J. Green, MD, Brian G. Till, MD, Oliver W. Press, MD, PhD, Ajay K. Gopal, MD

Blood (2013) 122 (21): 2106.

https://doi.org/10.1182/blood.V122.21.2106.2106

Published: 2013

Journal Articles

Randomized Comparison of Melphalan 200 Mg/m 2 v. 280 Mg/m 2 As a Preparative Regimen for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

William I. Bensinger, MD, Pamela S Becker, MD, PhD, Ted A. Gooley, PhD, Thomas Chauncey, MD, PhD, David G. Maloney, MD, PhD, Robert Vescio, MD, Ajay K. Gopal, MD, Damian J. Green, MD, Oliver W. Press, MD, PhD, Michael Lill, M.D., Leona Holmberg, MD, PhD, Jainulabdeen J Ifthikharuddin, MD, Gordon L. Phillips, II, MD

Blood (2012) 120 (21): 2009.

https://doi.org/10.1182/blood.V120.21.2009.2009

Published: 2012

Journal Articles

Improved Stem Cell Transplant Related Mortality for AL Amyloidosis At a Single Transplant Center

Zandra K. Klippel, MD, Barry Storer, PhD, William I. Bensinger, MD, Leona Holmberg, MD, PhD, Pamela S Becker, MD, PhD, Damian J. Green, MD, Nicholas Burwick, MD, Edward N. Libby, III, MD

Blood (2012) 120 (21): 2016.

https://doi.org/10.1182/blood.V120.21.2016.2016

Published: 2012

Journal Articles

Specific Features Identify Patients with Relapsed/Refractory Mantle Cell Lymphoma Benefitting From Autologous Hematopoietic Cell Transplantation.

Ryan D. Cassaday, MD, Katherine A. Guthrie, PhD, Lihua E. Budde, MD, PhD, Leslie Thompson, Brian G. Till, MD, Oliver W. Press, MD, PhD, Thomas Chauncey, MD, PhD, John M. Pagel, MD, PhD, Stephen H. Petersdorf, MD, William I. Bensinger, MD, Leona Holmberg, MD, PhD, Andrei R. Shustov, MD, Damian J. Green, MD, Edward N. Libby, III, MD, David G. Maloney, MD, PhD, Ajay K. Gopal, MD

Blood (2012) 120 (21): 3082.

https://doi.org/10.1182/blood.V120.21.3082.3082

Published: 2012

Journal Articles

Bendamustine (Treanda®), Etoposide and Dexamethasone (BED) Followed by GCSF Effectively Mobilizes Autologous Peripheral Blood Hematopoietic Stem Cells

Damian J. Green, MD, William I. Bensinger, MD, Leona Holmberg, MD, PhD, Theodore A. Gooley, PhD, Brian G. Till, MD, Lihua Elizabeth Budde, MD, PhD, Shani L. Frayo, BS, Jennifer E. Roden, Lacey Hedin, Oliver W. Press, MD, PhD, Ajay K. Gopal, MD

Blood (2012) 120 (21): 4126.

https://doi.org/10.1182/blood.V120.21.4126.4126

Published: 2012

Journal Articles

Chemo-Mobilization Provides Superior Mobilization and Collection in Autologous Stem Cell Transplants but with Less Predictability and At a Higher Cost,

Nelson J. Chao, MD, Daniel T Grima, M.Sc., George Carrum, MD, Leona Holmberg, MD., PhD, Henry C. Fung, FRCP, MD, Stephen Brown, Ph.D., Mitchell E. Horwitz, MD, Lisa M Bernard, M.Sc., Junya Kanda, MD, Jane L. Liesveld, MD, Brian McClune, DO, Paul Shaughnessy, MD, Guido J. Tricot, MD, PhD

Blood (2011) 118 (21): 4048.

https://doi.org/10.1182/blood.V118.21.4048.4048

Published: 2011

Journal Articles

The Pre-Transplant Mantle Cell Lymphoma International Prognostic Index Predicts Overall and Progression-Free Survival Following High-Dose Therapy and Autologus Stem Cell Transplant for Mantle Cell Lymphoma

Leslie A Thompson, Katherine A Guthrie, Lihua Elizabeth Budde, MD, PhD, Brian G. Till, MD, Oliver W. Press, MD, PhD, Thomas Chauncey, MD, PhD, John M. Pagel, MD, PhD, Stephen H. Petersdorf, MD, William I Bensinger, MD, Leona Holmberg, MD., PhD, Andrei R. Shustov, MD, Damian J. Green, MD, David G. Maloney, MD, PhD, Ajay K. Gopal, MD

Blood (2011) 118 (21): 2026.

https://doi.org/10.1182/blood.V118.21.2026.2026

Published: 2011

Journal Articles

Modified High-Dose Melphalan and Autologous Stem Cell Transplantation (mHDM/SCT) In the Treatment of AL Amyloidosis (AL) and/or High-Risk Myeloma (hM): Analysis of SWOG Trial S0115

Vaishali Sanchorawala, MD, Antje Hoering, PhD, David C Seldin, MD, PhD, Kathleen T Finn, ANP, Salli A Fennessey, Bassam I Mattar, MD, Hana F Safah, MD, Leona Holmberg, MD, PhD, Robert M. Dean, MD, Robert Z. Orlowski, MD, PhD, Bart Barlogie, MD, PhD

Blood (2011) 118 (21): 2004.

https://doi.org/10.1182/blood.V118.21.2004.2004

Published: 2011

Journal Articles

Differences in Stem Cell Collection Practices and Related Outcomes Between Centers That Conduct and Do Not Conduct Aphaeresis on Weekends

Nelson J. Chao, MD, Lisa M Bernard, M.Sc., George Carrum, MD, Henry C. Fung, FRCP, MD, Daniel T Grima, M.Sc., Leona Holmberg, MD., PhD, Stephen Brown, Ph.D., Mitchell E. Horwitz, MD, Junya Kanda, MD, Jane L. Liesveld, MD, Brian McClune, DO, Paul Shaughnessy, MD, Guido J. Tricot, MD, PhD

Blood (2011) 118 (21): 1925.

https://doi.org/10.1182/blood.V118.21.1925.1925

Published: 2011

Journal Articles

The Effective Use of Plerixafor as a Real-Time Rescue Strategy for Patients with Poorly Mobilizing Autologous CD34+ Cells

Ajay K Gopal, MD, Mehdi Karami, PharmD, JoAL Mayor, PharmD, Mylene Macabeo, RN, Michael L. Linenberger, MD, William Bensinger, MD, Leona Holmberg, MD., PhD

Blood (2010) 116 (21): 2251.

https://doi.org/10.1182/blood.V116.21.2251.2251

Published: 2010

NARROW

Consolidation with Nivolumab and Brentuximab Vedotin after Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma

Clinical Outcomes of Chronic Lymphocytic Leukemia (CLL) Patients with Richter's Transformation (RT) to Aggressive Non-Hodgkin Lymphoma (aNHL): a Single-Institution Experience

A Phase II Trial Evaluating the Efficacy of Radioiodinated Tositumomab (Anti-CD20) Antibody, Etoposide and Cyclophosphamide Followed By Autologous Transplantation, for High-Risk Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase II Trial of Bortezomib Plus Rituximab As Maintenance Therapy Post ASCT for Patients with Mantle Cell Lymphoma

Bone Marrow Involvement Detected By Multi-Parameter Flow Cytometry Predicts Poor Outcome after Autologous Stem Cell Transplantation for Peripheral T-Cell Lymphoma

Failure of Intensified Induction Therapy and Inability to Undergo Stem Cell Transplantation Predict Dismal Outcomes in Relapsed/Refractory MYC + B-Cell Lymphoma

Long Term Follow-up of High-Dose CD20-Targeted Radioimmunotherapy-Based Autologous Transplantation for Patients with Mantle Cell Lymphoma

Bendamustine (Treanda®)-Based Regimens Are Effective In Mobilizing Peripheral Blood Hematopoietic Stem Cells For Autologous Transplantation

Cost and Utilization Of Stored Autologous PBSC To Support Tandem ASCT In MM Patients In The Era Of Novel Agent Therapy

Impact Of Pre-Transplant Rituximab Sensitivity In Relapsed Follicular Lymphoma On Outcome After Autologous Transplant

Brentuximab Vedotin Administered To Platinum-Refractory Transplant Naïve Hodgkin Lymphoma Patients Can Increase The Proportion Achieving FDG-PET Negative Status

Randomized Comparison of Melphalan 200 Mg/m 2 v. 280 Mg/m 2 As a Preparative Regimen for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Improved Stem Cell Transplant Related Mortality for AL Amyloidosis At a Single Transplant Center

Specific Features Identify Patients with Relapsed/Refractory Mantle Cell Lymphoma Benefitting From Autologous Hematopoietic Cell Transplantation.

Bendamustine (Treanda®), Etoposide and Dexamethasone (BED) Followed by GCSF Effectively Mobilizes Autologous Peripheral Blood Hematopoietic Stem Cells

Chemo-Mobilization Provides Superior Mobilization and Collection in Autologous Stem Cell Transplants but with Less Predictability and At a Higher Cost,

The Pre-Transplant Mantle Cell Lymphoma International Prognostic Index Predicts Overall and Progression-Free Survival Following High-Dose Therapy and Autologus Stem Cell Transplant for Mantle Cell Lymphoma

Modified High-Dose Melphalan and Autologous Stem Cell Transplantation (mHDM/SCT) In the Treatment of AL Amyloidosis (AL) and/or High-Risk Myeloma (hM): Analysis of SWOG Trial S0115

Differences in Stem Cell Collection Practices and Related Outcomes Between Centers That Conduct and Do Not Conduct Aphaeresis on Weekends

The Effective Use of Plerixafor as a Real-Time Rescue Strategy for Patients with Poorly Mobilizing Autologous CD34+ Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only